Navigation Links
Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009
Date:6/8/2009

e in most patients.

If patients experience the following severe and persistent symptoms (alone or in combination): abdominal pain, nausea, vomiting, or diarrhea, they should talk to their healthcare provider because these symptoms could be signs of serious medical conditions. BYETTA may reduce appetite, the amount of food eaten, and body weight. No changes in dose are needed for these side effects. These are not all of the side effects from use of BYETTA. A healthcare provider should be consulted about any side effect that is bothersome or does not go away. For full prescribing information, visit www.BYETTA.com.

About Amylin and Lilly

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information about Amylin Pharmaceuticals is available at www.amylin.com.

Through a long-standing commitment to diabetes care, Lilly provides patients with breakthrough treatments that enable them to live longer, healthier and fuller lives. Since 1923, Lilly has been the industry leader in pioneering therapies to help healthcare professionals improve the lives of people with diabetes, and research continues on innovative medicines to address the unmet needs of patients. For more information about Lilly's current diabetes products visit, www.lillydiabetes.com.

'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
6. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
7. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
8. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
9. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
10. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Oct. 20, 2014  BioPontis Alliance for Rare ... philanthropies, announced today the creation of a joint ... of the rare disease known as Charcot- Marie-Tooth ... alliance model earlier this month. Today,s partnership announcement ... collaborative model where researchers and all CMT dedicated ...
(Date:10/19/2014)... , Oct. 20, 2014 CTI BioPharma Corp. ... will report its third quarter 2014 financial results on ... U.S. financial markets. Following the announcement, members of the ... discuss the results and provide a general corporate update ... the event can be obtained as follows: ...
(Date:10/19/2014)... October 19, 2014 Große ... Das Problem dabei ist, dass große Pharmafirmen ... Kompetenz zu teilen. Es war deshalb ... wir uns umso mehr, dass es uns gelungen ... bei Kühlketten aufzuschreiben - mit einem Vorbehalt - ...
Breaking Medicine Technology:The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 2Vergleichsbericht zu Pharma-Kühlketten und CRT 2
... its entry into the Omaha market today with ... new stores in the city of Omaha.  Joining ... Jim Suttle, Mayor of Omaha and City Councilmember ... http://www.newscom.com/cgi-bin/prnh/20100816/NE50800LOGO) Omaha is the latest market ...
... 16 PLC Systems Inc. (OTC Bulletin Board: ... medical device-based technologies, today reported financial results for the three- ... Second quarter 2010 total revenues were $1,019,000, a decrease ... a decrease of $43,000 from $1,062,000 reported in the first ...
Cached Medicine Technology:CVS/pharmacy Enters Omaha Market 2PLC Systems Reports Second Quarter 2010 Results 2PLC Systems Reports Second Quarter 2010 Results 3PLC Systems Reports Second Quarter 2010 Results 4PLC Systems Reports Second Quarter 2010 Results 5
(Date:10/19/2014)... (PRWEB) October 20, 2014 Having been working ... a good knowledge of customer needs. According to James, one ... covered with dazzling sequins, or with high-low skirts that add ... a huge demand. Recently, LunaDress has unveiled its new selection ... of fact, the company’s brand new items are available in ...
(Date:10/19/2014)... Recently, Fancyflyingfox.com, an innovative company that ... announced its latest designs of 2014 mother of ... elegant outfits are offered with big discounts, up to ... October 30 can enjoy this special offer. , ... it has become one of the leading brands in ...
(Date:10/19/2014)... Visual Impact Frequency Training - ... released to the public generating a frenzied buzz ... fitness community. The commotion surrounding the program's launch ... prompting an investigative review. , "Many gym-goers are ... commonly known as a training 'plateau' where they ...
(Date:10/19/2014)... New stem cell-based research could improve understanding of intestinal ... study suggests. Scientists used stem cells to grow ... dish. They then transplanted the organoids into mice, creating ... the researchers. "This provides a new way to ... intestinal failure, from genetic disorders appearing at birth to ...
(Date:10/19/2014)... The U.S. Government has initiated a major effort ... 2025. However, a workgroup of nearly 40 Alzheimer,s ... the U.S. Government,s National Plan to Address Alzheimer,s ... scale, and adequately funded in order to successfully ... the workgroup to enlarge and strengthen the Plan ...
Breaking Medicine News(10 mins):Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Fancyflyingfox.com Updates Its Website With New Mother Of The Bride Dresses For 2014 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2Health News:Scientists Grow, Implant Human Intestinal Tissue in Mice 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 2Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 3Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 4Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 5Health News:Scientists say national Alzheimer's plan milestones must be strengthened to meet goal by 2025 6
... Patients are urged,to suggest candidates for ... participation is vital; many past award winners ... sponsored by the Pennsylvania Academy of Family,Physicians ... provides compassionate, comprehensive care. Eligible nominees must ...
... 16 Americans consume more calories as a,nation on Super ... save,Thanksgiving. By the time the final whistle blows at Super ... greasy pizza,fried chicken wings, and beer., But this year ... of the,football field 109 times to burn off all of ...
... at the Johns Hopkins Brady Urological Institute, Wake Forest University ... of gene markers for hereditary prostate cancer that, along with ... more than nine times that of men without such markers. ... 4,000 Swedes, found that these markers are common and could ...
... history can increase risk up to tenfold, study suggests, , , ... that looks at five genetic variants could one day predict ... , Researchers found that among men with four of the ... percent to 500 percent, compared to men with none of ...
... prevention experts from the University of North Carolina at ... Medicine and Duke University Medical Center will undertake a ... project, the largest and most comprehensive in the country, ... Prevention, the Doris Duke Charitable Foundation and The Duke ...
... cells in the lungs of patients diagnosed with ... death, University of Cincinnati (UC) researchers have discovered. ... of neutrophil (pronounced new-tro-fil) cellsa type of white ... 30 percent increased risk of mortality in the ...
Cached Medicine News:Health News:Nominate Your Family Doctor for Family Physician of the Year 2Health News:Eat This, Not That!(TM): 5 Smart Super Bowl Swaps That Will Save You Hundreds of Calories 2Health News:Gene markers located for hereditary prostate cancer 2Health News:Gene markers located for hereditary prostate cancer 3Health News:Genetic Mutations Boost Prostate Cancer Risk 2Health News:Genetic Mutations Boost Prostate Cancer Risk 3Health News:UNC, Duke lead first statewide shaken baby prevention research project in US 2Health News:UNC, Duke lead first statewide shaken baby prevention research project in US 3Health News:UNC, Duke lead first statewide shaken baby prevention research project in US 4Health News:Rare lung disease cells indicate higher death risk 2
... a sterile, single use bundle of absorbent matrix ... The synthetic matrix absorbs excess exudate fluid, swells ... slough and necrotic debris within its strands to ... matrix are bound together by a matrix bridge ...
A non-adhering hydrogel sheet dressing for use on all partial and full thickness wounds (excluding 3rd degree burns.) Hydrogel sheet contains 96% water and 4% insoluble cross-linked polyethylene oxid...
... a comprehensive Clinical Information System promoting ... implementation of this system, because it ... and patient accounting information. The integration ... of streamlined processes and a valuable ...
... easy, intuitive routines for quick set up ... features along with unparalleled integration provide a ... calculates charges, bills patients, decrements inventory and ... The system's many powerful features enable nursing ...
Medicine Products: